Cytochrome P450 3A

• Accelerating drug development in infectious diseases using zebrafish disease models supported by pharmacokinetic-pharmacodynamic modeling as new approach methodology (NAM)

  2026 bioRxiv (Cold Spring Harbor Laboratory) preprint Biochemistry, Genetics and Molecular Biology Zebrafish Biomedical Research Applications Open access

  1

  citations
• Implementing Pre‐Emptive Pharmacogenetics: Impact of Early Pharmacogenetic Screening in a Pediatric Oncology Cohort of 1,151 Subjects

  2025 Clinical Pharmacology & Therapeutics article Pharmacology, Toxicology and Pharmaceutics Pharmacogenetics and Drug Metabolism Open access

  9

  citations
• Physiologically based modeling reveals different risk of respiratory depression after fentanyl overdose between adults and children

  2024 Clinical and Translational Science article Medicine Opioid Use Disorder Treatment Open access

  4

  citations
• Unraveling the Effects of Acute Inflammation on Pharmacokinetics: A Model-Based Analysis Focusing on Renal Glomerular Filtration Rate and Cytochrome P450 3A4-Mediated Metabolism

  2023 European Journal of Drug Metabolism and Pharmacokinetics article Pharmacology, Toxicology and Pharmaceutics Pharmacogenetics and Drug Metabolism Open access

  9

  citations
• The Oral Bioavailability and Metabolism of Midazolam in Stable Critically Ill Children: A Pharmacokinetic Microtracing Study

  2020 Clinical Pharmacology & Therapeutics article Medicine Pharmaceutical studies and practices Open access

  31

  citations
• Usage of Tacrolimus and Mycophenolic Acid During Conception, Pregnancy, and Lactation, and Its Implications for Therapeutic Drug Monitoring: A Systematic Critical Review

  2020 Therapeutic Drug Monitoring article Medicine Pregnancy and Medication Impact Open access

  49

  citations

6 results